de Moor R A, Mourad L, ter Haar J, Egberts A C
Afd. Kindergeneeskunde, TweeSteden ziekenhuis, Postbus 90.107, 5000 LA Tilburg.
Ned Tijdschr Geneeskd. 2003 Jul 12;147(28):1370-2.
Withdrawal symptoms occurred in a male neonate after maternal use of venlafaxine for depression during pregnancy. The symptoms were restlessness, hypertonia, jitteriness, irritability and poor feeding. The diagnosis was confirmed by a temporary improvement after administration of a low dose (1 mg) of venlafaxine to the boy. Eventually the symptoms began to decline spontaneously, and ceased after 8 days. Exposure to venlafaxine and other antidepressants which inhibit serotonin reuptake during the third trimester of pregnancy carries the risk of a neonatal withdrawal syndrome.
一名男婴在其母亲孕期使用文拉法辛治疗抑郁症后出现了戒断症状。症状包括烦躁不安、肌张力亢进、震颤、易怒和喂养困难。给该男婴服用低剂量(1毫克)文拉法辛后症状暂时改善,从而确诊。最终症状开始自行减轻,并在8天后消失。在妊娠晚期接触文拉法辛和其他抑制5-羟色胺再摄取的抗抑郁药会有新生儿戒断综合征的风险。